• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Tradr to Launch Leveraged ETFs on BLSH, DASH, FLY, IREN, NEM, OPEN, QS, SRPT & WULF

    10/21/25 6:46:00 AM ET
    $BLSH
    $DASH
    $FLY
    $IREN
    Finance: Consumer Services
    Finance
    EDP Services
    Technology
    Get the next $BLSH alert in real time by email

    Nine funds are single-stock leveraged ETFs seeking 200% long exposure

    NEW YORK, Oct. 21, 2025 /PRNewswire/ -- Tradr ETFs, a provider of ETFs designed for sophisticated investors and professional traders, announced that it expects to launch nine new single stock leveraged ETFs on Thursday, October 23. The funds will be listed on Cboe, and each ETF aims to deliver twice (200%) the daily performance of its specific underlying stock.

    Expected Tradr launches:

    • Tradr 2X Long BLSH Daily ETF (Cboe: BLSX) – tracks Bullish Limited (NYSE:BLSH)
    • Tradr 2X Long DASH Daily ETF (Cboe: DASX) – tracks DoorDash, Inc. (NASDAQ:DASH)
    • Tradr 2X Long FLY Daily ETF (Cboe: FLYT) – tracks Firefly Aerospace, Inc. (NASDAQ:FLY)
    • Tradr 2X Long IREN Daily ETF (Cboe: IREX) – tracks IREN Limited (NASDAQ:IREN)
    • Tradr 2X Long NEM Daily ETF (Cboe: NWMX) – tracks Newmont Corporation (NYSE:NEM)
    • Tradr 2X Long OPEN Daily ETF (Cboe: OPEX) – tracks Opendoor Technologies Inc. (NASDAQ:OPEN)
    • Tradr 2X Long QS Daily ETF (Cboe: QSX) – tracks QuantumScape Corporation (NYSE:QS)
    • Tradr 2X Long SRPT Daily ETF (Cboe: SRPU) – tracks Sarepta Therapeutics, Inc. (NASDAQ:SRPT)
    • Tradr 2X Long WULF Daily ETF (Cboe: WULX) – tracks TeraWulf, Inc. (NASDAQ:WULF)

    For detailed information on Tradr ETFs and the significant risks involved with leveraged ETFs, please visit www.tradretfs.com.

    The Prospectus for these funds is not yet effective or complete and may be changed. Tradr may not sell these securities until the registration statement filed with the Securities and Exchange Commission is effective. The Prospectus is not an offer to sell these securities, and it is not soliciting an offer to buy these securities in any state where the offer of sale is not permitted.

    About Tradr ETFs

    Tradr ETFs are designed for sophisticated investors and professional traders who are looking to express high conviction investment views. The strategies include leveraged and inverse ETFs that seek short or long exposure to actively traded stocks and ETFs.

    IMPORTANT RISK INFORMATION

    Tradr ETFs are for sophisticated investors and professional traders with high conviction views and are very different from most other ETFs. The Funds are intended to be used as short-term trading vehicles and pursue leveraged investment objectives, which means they are riskier than alternatives that do not use leverage because the Funds magnify the performance of their underlying security. The volatility of the underlying security may affect a Fund's return as much as, or more than, the return of the underlying security.

    Investors in the fund should: (a) understand the risks associated with the use of leverage; (b) understand the consequences of seeking inverse and leveraged investment results; (c) for short ETFs, understand the risk of shorting; (d) intend to actively monitor and manage their investment. Fund performance will likely be significantly different than the benchmark over periods longer than the specified reset period and the performance may trend in the opposite direction than its benchmark over periods other than that period.

    Leverage increases the risk of a total loss of an investor's investment, may increase the volatility of the Funds, and may magnify any differences between the performance of the Funds and their reference security. The Funds seek leveraged investment results for a specific period (daily, monthly or quarterly). The exact exposure of an investment in the Fund intra-period will depend upon the movement of the reference security from the end of the prior period until the time of investment by the investor.

    The Fund will not attempt to position its portfolio to ensure it does not gain or lose more than a maximum percentage of its net asset value on a given trading day. As a consequence, investors in a Fund that seeks two times daily performance would lose all of their money if the Fund's underlying security moves more than 50% in a direction adverse to the Fund on a given trading day.

    ETFs involve risk including possible loss of the full principal value. There is no assurance that the Fund will achieve its investment objective. Principal risks and other important risks may be found in the prospectus. Past performance does not guarantee future results.

    ETF shares are bought and sold at market price (not NAV) and are not individually redeemed from the ETF. There can be no guarantee that an active trading market for ETF shares will develop or be maintained, or that their listing will continue or remain unchanged. Buying or selling ETF shares on an exchange may require the payment of brokerage commissions and frequent trading may incur brokerage costs that detract significantly from investment returns.

    Investors should carefully consider the investment objectives, risks, charges and expenses of the Funds. This and other important information about the Fund is contained in the Prospectus, which can be obtained by visiting www.tradretfs.com. The Prospectus should be read carefully before investing.

    Distributed by ALPS Distributors, Inc, which is not affiliated with AXS Investments or its Tradr ETFs. AXI000769

    (PRNewsfoto/Tradr ETFs)

    Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/tradr-to-launch-leveraged-etfs-on-blsh-dash-fly-iren-nem-open-qs-srpt--wulf-302589681.html

    SOURCE Tradr ETFs

    Get the next $BLSH alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $BLSH
    $DASH
    $FLY
    $IREN

    CompanyDatePrice TargetRatingAnalyst
    TeraWulf Inc.
    $WULF
    3/23/2026$30.00Buy
    Arete
    Newmont Corporation
    $NEM
    2/27/2026$157.00Mkt Perform → Outperform
    Bernstein
    Newmont Corporation
    $NEM
    2/20/2026$145.00 → $140.00Outperform
    BMO Capital Markets
    QuantumScape Corporation
    $QS
    2/19/2026$8.30Reduce → Hold
    HSBC Securities
    TeraWulf Inc.
    $WULF
    2/9/2026$37.00Overweight
    Morgan Stanley
    Sarepta Therapeutics Inc.
    $SRPT
    1/28/2026$20.00Equal Weight
    Barclays
    Bullish
    $BLSH
    1/15/2026$55.00 → $52.00Buy
    Rosenblatt
    DoorDash Inc.
    $DASH
    1/14/2026$280.00Outperform
    BNP Paribas Exane
    More analyst ratings

    $BLSH
    $DASH
    $FLY
    $IREN
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Arete initiated coverage on TeraWulf with a new price target

    Arete initiated coverage of TeraWulf with a rating of Buy and set a new price target of $30.00

    3/23/26 8:29:37 AM ET
    $WULF
    EDP Services
    Technology

    Newmont Corporation upgraded by Bernstein with a new price target

    Bernstein upgraded Newmont Corporation from Mkt Perform to Outperform and set a new price target of $157.00

    2/27/26 8:22:06 AM ET
    $NEM
    Precious Metals
    Basic Materials

    BMO Capital Markets reiterated coverage on Newmont Corporation with a new price target

    BMO Capital Markets reiterated coverage of Newmont Corporation with a rating of Outperform and set a new price target of $140.00 from $145.00 previously

    2/20/26 8:00:16 AM ET
    $NEM
    Precious Metals
    Basic Materials

    $BLSH
    $DASH
    $FLY
    $IREN
    SEC Filings

    View All

    Amendment: SEC Form SCHEDULE 13G/A filed by Opendoor Technologies Inc

    SCHEDULE 13G/A - Opendoor Technologies Inc. (0001801169) (Subject)

    4/8/26 4:55:30 PM ET
    $OPEN
    Real Estate
    Finance

    SEC Form 6-K filed by Bullish

    6-K - Bullish (0001872195) (Filer)

    4/8/26 6:45:28 AM ET
    $BLSH
    Finance: Consumer Services
    Finance

    SEC Form 424B3 filed by Firefly Aerospace Inc.

    424B3 - Firefly Aerospace Inc. (0001860160) (Filer)

    4/3/26 4:58:53 PM ET
    $FLY
    Military/Government/Technical
    Industrials

    $BLSH
    $DASH
    $FLY
    $IREN
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    SEC Form 4 filed by Tang Stanley

    4 - DoorDash, Inc. (0001792789) (Issuer)

    4/6/26 4:05:15 PM ET
    $DASH
    EDP Services
    Technology

    SEC Form 4 filed by Blumer Brendan Francis

    4 - Bullish (0001872195) (Issuer)

    4/6/26 10:57:01 AM ET
    $BLSH
    Finance: Consumer Services
    Finance

    SEC Form 4 filed by Hettrich Kevin

    4 - QuantumScape Corp (0001811414) (Issuer)

    4/3/26 6:13:03 PM ET
    $QS
    Industrial Machinery/Components
    Miscellaneous

    $BLSH
    $DASH
    $FLY
    $IREN
    FDA approvals

    Live FDA approvals issued by the Food and Drug Administration and FDA breaking news

    View All

    FDA Approval for AMONDYS 45 issued to SAREPTA THERAPS INC

    Submission status for SAREPTA THERAPS INC's drug AMONDYS 45 (SUPPL-8) with active ingredient CASIMERSEN has changed to 'Approval' on 07/11/2024. Application Category: NDA, Application Number: 213026, Application Classification: Labeling

    7/12/24 4:40:36 AM ET
    $SRPT
    Biotechnology: Pharmaceutical Preparations
    Health Care

    June 20, 2024 - FDA Expands Approval of Gene Therapy for Patients with Duchenne Muscular Dystrophy

    For Immediate Release: June 20, 2024 Today, the U.S. Food and Drug Administration expanded the approval of Elevidys (delandistrogene moxeparvovec-rokl), a gene therapy for the treatment of Duchenne muscular dystrophy (DMD) for ambulatory and non-ambulatory individuals 4 years of age and older with DMD with a confirmed mutation in the DMD gene.  Elevidys was previously approved under accelerated approval for amb

    6/20/24 5:24:42 PM ET
    $SRPT
    Biotechnology: Pharmaceutical Preparations
    Health Care

    FDA Approval for VYONDYS 53 issued to SAREPTA THERAPS INC

    Submission status for SAREPTA THERAPS INC's drug VYONDYS 53 (SUPPL-11) with active ingredient GOLODIRSEN has changed to 'Approval' on 06/04/2024. Application Category: NDA, Application Number: 211970, Application Classification: Labeling

    6/5/24 4:41:31 AM ET
    $SRPT
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $BLSH
    $DASH
    $FLY
    $IREN
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Bucella Michael C. bought $19,950 worth of shares (1,338 units at $14.91), increasing direct ownership by 0.49% to 273,552 units (SEC Form 4)

    4 - TERAWULF INC. (0001083301) (Issuer)

    3/13/26 5:49:13 PM ET
    $WULF
    EDP Services
    Technology

    Director Bucella Michael C. bought $30,071 worth of shares (2,085 units at $14.42), increasing direct ownership by 0.77% to 272,214 units (SEC Form 4)

    4 - TERAWULF INC. (0001083301) (Issuer)

    3/9/26 7:31:19 PM ET
    $WULF
    EDP Services
    Technology

    Director Bucella Michael C. bought $50,038 worth of shares (3,171 units at $15.78), increasing direct ownership by 1% to 270,129 units (SEC Form 4)

    4 - TERAWULF INC. (0001083301) (Issuer)

    3/4/26 5:34:43 PM ET
    $WULF
    EDP Services
    Technology

    $BLSH
    $DASH
    $FLY
    $IREN
    Financials

    Live finance-specific insights

    View All

    QuantumScape Announces Timing of First Quarter 2026 Business Results and Webcast

    SAN JOSE, Calif., April 08, 2026 (GLOBE NEWSWIRE) -- QuantumScape Corporation (NASDAQ:QS), a global leader in next-generation solid-state lithium-metal battery technology, today announced it will release its 2026 first-quarter business results after market close on Wednesday, April 22, 2026. This will be followed by a conference call at 2 p.m. Pacific Time (5 p.m. Eastern Time). Siva Sivaram, chief executive officer, and Kevin Hettrich, chief financial officer, will participate on the call. Starting today, April 8, shareholders can submit questions (here) they would like addressed on the call. QuantumScape management will respond to a selection of the submitted questions. The company will

    4/8/26 4:15:00 PM ET
    $QS
    Industrial Machinery/Components
    Miscellaneous

    Newmont Announces First Quarter 2026 Results Conference Call

    Newmont Corporation (NYSE:NEM, ASX: NEM, PNGX: NEM)) will release its first quarter 2026 results after North American markets close on Thursday, April 23, 2026. A conference call to discuss the results will be held at 5:30 p.m. Eastern Daylight Time the same day, which is 7:30 a.m. Australian Eastern Standard Time on Friday, April 24, 2026. A replay of the webcast will be available through the Company's website. Webcast Details Title: Newmont's First Quarter 2026 Results Conference Call Attendee URL: https://events.q4inc.com/attendee/351410623 Analyst Registration for Q&A: https://events.q4inc.com/analyst/351410623?pwd=1xsDlN9Y The webcast materials will be available Thursday, April 23

    3/31/26 4:15:00 PM ET
    $NEM
    Precious Metals
    Basic Materials

    Sarepta to Share First Clinical Data from siRNA Pipeline Targeting FSHD1 and DM1

    Sarepta Therapeutics, Inc. (NASDAQ:SRPT), the leader in precision genetic medicine for rare diseases, today announced that on Wed., March 25, 2026, at 8:30 am Eastern Time, the Company will host a webcast and conference call to present the early clinical results from the Phase 1/2 ascending dose studies of SRP-1001 for facioscapulohumeral muscular dystrophy type 1 (FSHD1) and SRP-1003 for myotonic dystrophy type 1 (DM1). The event will be webcast live under the investor relations section of Sarepta's website at https://investorrelations.sarepta.com/events-presentations and following the event a replay will be archived there for one year. Interested parties participating by phone will need

    3/24/26 4:05:00 PM ET
    $SRPT
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $BLSH
    $DASH
    $FLY
    $IREN
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    QuantumScape Announces Timing of First Quarter 2026 Business Results and Webcast

    SAN JOSE, Calif., April 08, 2026 (GLOBE NEWSWIRE) -- QuantumScape Corporation (NASDAQ:QS), a global leader in next-generation solid-state lithium-metal battery technology, today announced it will release its 2026 first-quarter business results after market close on Wednesday, April 22, 2026. This will be followed by a conference call at 2 p.m. Pacific Time (5 p.m. Eastern Time). Siva Sivaram, chief executive officer, and Kevin Hettrich, chief financial officer, will participate on the call. Starting today, April 8, shareholders can submit questions (here) they would like addressed on the call. QuantumScape management will respond to a selection of the submitted questions. The company will

    4/8/26 4:15:00 PM ET
    $QS
    Industrial Machinery/Components
    Miscellaneous

    Former U.S. Air Force Chief Scientist Dr. Mark Maybury Joins QuantumScape Strategic Advisory Board

    SAN JOSE, Calif., April 08, 2026 (GLOBE NEWSWIRE) -- QuantumScape Corporation (NASDAQ:QS), a global leader in next-generation solid-state lithium-metal battery technology, today announced Dr. Mark Maybury has joined its strategic advisory board. Dr. Maybury brings decades of leadership experience spanning defense, artificial intelligence, cybersecurity, digital transformation, and advanced manufacturing– further strengthening QS's push into additional markets. Dr. Maybury currently serves as Vice President of Commercialization, Engineering and Technology at Lockheed Martin, where he leads the transition of cutting-edge research into scalable products for commercial and defense application

    4/8/26 9:00:00 AM ET
    $QS
    Industrial Machinery/Components
    Miscellaneous

    Firefly Aerospace Enables On-Orbit Processing for Moon Imaging Service with NVIDIA Jetson

    CEDAR PARK, Texas, April 08, 2026 (GLOBE NEWSWIRE) -- Firefly Aerospace (NASDAQ:FLY), a market leading space and defense technology company, today announced a collaboration with NVIDIA to enable rapid on-orbit processing in lunar orbit for Firefly's Ocula Moon imaging service. As part of the collaboration, an NVIDIA Jetson module was embedded on high-resolution Lawrence Livermore National Laboratory telescopes and delivered to Firefly's spacecraft facility ahead of integration on its Elytra orbital vehicle. "Ocula is set to be the first commercial lunar imaging and mapping service available on the market, and it's coming at a critical time when other government-owned satellites in l

    4/8/26 9:00:00 AM ET
    $FLY
    Military/Government/Technical
    Industrials

    $BLSH
    $DASH
    $FLY
    $IREN
    Leadership Updates

    Live Leadership Updates

    View All

    Former U.S. Air Force Chief Scientist Dr. Mark Maybury Joins QuantumScape Strategic Advisory Board

    SAN JOSE, Calif., April 08, 2026 (GLOBE NEWSWIRE) -- QuantumScape Corporation (NASDAQ:QS), a global leader in next-generation solid-state lithium-metal battery technology, today announced Dr. Mark Maybury has joined its strategic advisory board. Dr. Maybury brings decades of leadership experience spanning defense, artificial intelligence, cybersecurity, digital transformation, and advanced manufacturing– further strengthening QS's push into additional markets. Dr. Maybury currently serves as Vice President of Commercialization, Engineering and Technology at Lockheed Martin, where he leads the transition of cutting-edge research into scalable products for commercial and defense application

    4/8/26 9:00:00 AM ET
    $QS
    Industrial Machinery/Components
    Miscellaneous

    QuantumScape Appoints Defense Executive Ross Niebergall to Board of Directors

    QuantumScape Corporation (NASDAQ:QS), a global leader in next-generation solid-state lithium-metal battery technology, today announced the appointment of Ross Niebergall to its board of directors. Niebergall is an experienced executive with decades of service in the defense sector, leading R&D and technology commercialization in defense applications for multiple defense primes. Niebergall was most recently President of Aerojet Rocketdyne after its acquisition by L3Harris. He was Chief Technology Officer of L3Harris and Harris Corporation from 2017 to 2023. Previous to Harris Corporation, he was Vice President, Engineering at Raytheon and served as CEO of ThalesRaytheon Systems LLC, a join

    3/5/26 9:00:00 AM ET
    $QS
    Industrial Machinery/Components
    Miscellaneous

    IREN Appoints John Gross as Chief Innovation Officer

    NEW YORK, Feb. 17, 2026 (GLOBE NEWSWIRE) -- IREN Limited (NASDAQ:IREN) ("IREN") today announced the appointment of John Gross as Chief Innovation Officer, a newly established role responsible for leading engineering standards, thermal architecture, and commissioning across IREN's next-generation data centers. Mr. Gross is a globally recognized leader in data center engineering, with two decades of industry experience and deep expertise in high-density and liquid-cooled data center design. He serves as Vice Chair of committees within ASHRAE (American Society of Heating, Refrigerating and Air-Conditioning Engineers), which develops global standards for high-density and liquid-cooled data ce

    2/17/26 5:00:50 AM ET
    $IREN
    EDP Services
    Technology

    $BLSH
    $DASH
    $FLY
    $IREN
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13G/A filed by Sarepta Therapeutics Inc.

    SC 13G/A - Sarepta Therapeutics, Inc. (0000873303) (Subject)

    11/13/24 10:27:59 AM ET
    $SRPT
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Amendment: SEC Form SC 13G/A filed by TeraWulf Inc.

    SC 13G/A - TERAWULF INC. (0001083301) (Subject)

    11/12/24 5:47:40 PM ET
    $WULF
    EDP Services
    Technology

    Amendment: SEC Form SC 13G/A filed by Newmont Corporation

    SC 13G/A - NEWMONT Corp /DE/ (0001164727) (Subject)

    11/12/24 4:43:51 PM ET
    $NEM
    Precious Metals
    Basic Materials